Hawkinson Russ 4
4 · Silverback Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Hawkinson Russ
Sr. Vice President of Finance
Transactions
- Award
Stock Option (right to buy)
2022-02-01+45,000→ 45,000 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (45,000 underlying) - Award
Common Stock
2022-02-01+7,500→ 8,954 total - Award
Stock Option (right to buy)
2022-02-01+28,500→ 28,500 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (28,500 underlying)
Footnotes (4)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 1,216 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2021.
- [F3]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F4]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.